EP 0111560 A4 19870203 - SUSTAINED RELEASE ASPIRIN.
Title (en)
SUSTAINED RELEASE ASPIRIN.
Title (de)
ASPIRIN MIT KONTINUIERLICHER ABGABE.
Title (fr)
ASPIRINE A LIBERATION ENTRETENUE.
Publication
Application
Priority
US 38818382 A 19820614
Abstract (en)
[origin: WO8400004A1] A sustained release aspirin dosage form permits the continuous delivery of aspiring into the gastrointestinal tract for a period of at least eight hours. The sustained release aspirin dosage form comprises a plurality of polymerically coated aspirin crystals each of which comprises an aspirin seed. The majority of aspirin seeds have a mesh size of from about 30 to about 60 mesh. Each of the aspirin seeds is individually coated with a polymeric mixture, which comprises from about 1.5 to about 15 parts by weight ethylcellulose and about one part by weight hydroxypropylcellulose.
IPC 1-7
IPC 8 full level
A61K 9/22 (2006.01); A61K 9/50 (2006.01); A61K 9/62 (2006.01); A61K 31/60 (2006.01)
CPC (source: EP)
A61K 9/5047 (2013.01); A61K 31/60 (2013.01)
Citation (search report)
- No relevant documents have been disclosed
- No relevant documents have been disclosed
Designated contracting state (EPC)
AT BE CH DE FR GB LI LU NL SE
DOCDB simple family (publication)
WO 8400004 A1 19840105; EP 0111560 A1 19840627; EP 0111560 A4 19870203
DOCDB simple family (application)
US 8300928 W 19830614; EP 83902361 A 19830614